OOIR: Observatory of International Research

Papers

(The H4-Index of Bioorganic & Medicinal Chemistry is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Current Japanese pharmaceutical chemistry	95
Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation	73
Contents continued	68
Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice	57
Editorial Board	56
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling	52
Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation	45
Development of delivery carriers for plasmid DNA by conjugation of a helical template to oligoarginine	45
Exploring novel A2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents	44
Graphical abstract TOC	44
Innovative synthesis and purification method of fluorescent and bifunctional substrates for self-labelling protein tags	42
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors	41
Design, synthesis and antibacterial evaluation of oxazolidinone derivatives containing N-methylglycyl or quaternary ammonium salts	40
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds	39
Sustainable electrochemical C(sp3) − H oxygenation using water as the oxygen source	37
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues	35
Decades old glitazones still find niche in drug discoveries as PPAR-γ agonists: medicinal chemistry perspective, structure-activity relationships and therapeutic implications	34
A multifunctional hydrogel for synergistic dendritic cell activation and immunogenic cell death induction in enhanced chemoimmunotherapy	33
Multiple approaches to repurposing drugs for neuroblastoma	33
Sulfadoxine derivatization through multicomponent reactions to obtain new antiplasmodial compounds	33
Design, synthesis, biological activity and molecular docking studies of triazolopyridine derivatives as ASK1 inhibitors	33
Discovery of trisubstituted meta-carboranes as T cell activators by regulating CD28 cytoplasmic region and SH2 domains of Grb2 and PI3K interactions	32
Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents	31
Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors	31
Targeting m6A binding protein YTHDFs for cancer therapy	30

Natural product-derived antifungals against Candida albicans: Chemical diversity and mechanisms of action	29
Janus dendritic ionizable lipids with fine designed headgroup and tails to improve mRNA delivery efficiency	29
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development	29
Synthesis, evaluation of anti-breast cancer activity in vitro of ICS II derivatives and summary of the structure-activity relationship	29
Research progress of STAT3-based dual inhibitors for cancer therapy	29